We are pleased to announce the release of our updated profiling panels and kinase assay services effective July 4, 2011. To provide you with selectivity and IC50 data faster, the number of assays on our preferred platform, the Mobility Shift Assay (MSA) has been expanded. The IMAPTM platform continues to be in use for selected kinases. Most of the MAP kinases are now tested in cascade assays as part of our updated services.
Assays for compounds received by June 9 will be performed under the current system. Assays for compounds received thereafter will be performed under the new system starting July 4, 2011. We apologize for any inconvenience this may cause. The shift to the new system will result in a pause in our line operations from June 27 to July 1.
We welcome your request for our services at any time. To apply, please download our new application form from our website and submit to us at info@carnabio.com.
For more information, please feel free to inquire at info@carnabio.com.